Hear About Other Patients With Partial Seizures Who Have Added Oxtellar XR to Their Daily Treatment

Learning from the stories of others who have gone through similar treatment journeys and challenges can be helpful when considering your own treatment options. Here, you can review the experiences of doctors who have added once-a-day Oxtellar XR to the treatment plans of their patients still having partial seizures.*

Read the featured stories below to learn how patients like you have added Oxtellar XR to help control their partial seizures.

*Individual results may vary.

Kate struggled with partial seizures for years, largely because we could not optimize her treatment regimen. Adding once-daily Oxtellar XR led to a reduction in seizures.

Mark S. Yerby, MD
Owner and Operator, North Pacific Epilepsy Research
Bend, OR
Patient names and images have been changed to protect the actual patients. Individual results may vary.

JoAnn is a 46-year-old patient who had previously taken Trileptal®, Depakote®, and generic oxcarbazepine in combination with Depakote for partial seizures. With this regimen, she had alternating periods of doing fine and breakthrough partial seizures. Since replacing the generic oxcarbazepine with once-daily Oxtellar XR, she has been partial seizure free for many months.

Paul N. Chervin, MD
Clinical Instructor, Neurology, Harvard Medical School
Boston, MA
Patient names and images have been changed to protect the actual patients. Individual results may vary.

Eric is a 35-year-old patient with partial seizures and cerebral palsy. Once-daily Oxtellar XR was added into the mix of his partial seizure medications, and another partial seizure medication was discontinued. Over time, we increased the dosage of Oxtellar XR and decreased other partial seizure medication dosages, resulting in better partial seizure control over the last 6 months.

Robert M. Nieto, MD
Physician, Neurology Associates of Arlington
Mansfield, TX
Patient names and images have been changed to protect the actual patients. Individual results may vary.

The testimonials included are from physicians who have a consulting arrangement with Supernus Pharmaceuticals, Inc.